Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.3.1.2 extracted from

  • Shirasaka, T; Shimamato, Y; Ohshimo, H; Yamaguchi, M; Kato, T; Yonekura, K; Fukushima, M
    Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. (1996), Anticancer Drugs, 7, 548-57.
    View publication on PubMed
Search for more literature for 1.3.1.2

Organism

Organism UniProt Comment Textmining